Carbon monoxide actuates O(2)-limited heme degradation in the rat brain.
The biochemical paradigm for carbon monoxide (CO) is driven by the century-old Warburg hypothesis: CO alters O(2)-dependent functions by binding heme proteins in competitive relation to 1/oxygen partial pressure (PO(2)). High PO(2) thus hastens CO elimination and toxicity resolution, but with more O(2), CO-exposed tissues paradoxically experience less oxidative stress. To help resolve this paradox we tested the Warburg hypothesis using a highly sensitive gas-reduction method to track CO uptake and elimination in brain, heart, and skeletal muscle in situ during and after exogenous CO administration. We found that CO administration does increase tissue CO concentration, but not in strict relation to 1/PO(2). Tissue gas uptake and elimination lag behind blood CO as predicted, but 1/PO(2) vs. [CO] fails even at hyperbaric PO(2). Mechanistically, we established in the brain that cytosol heme concentration increases 10-fold after CO exposure, which sustains intracellular CO content by providing substrate for heme oxygenase (HO) activated after hypoxia when O(2) is resupplied to cells rich in reduced pyridine nucleotides. We further demonstrate by analysis of CO production rates that this heme stress is not due to HO inhibition and that heme accumulation is facilitated by low brain PO(2). The latter becomes rate limiting for HO activity even at physiological PO(2), and the heme stress leads to doubling of brain HO-1 protein. We thus reveal novel biochemical actions of both CO and O(2) that must be accounted for when evaluating oxidative stress and biological signaling by these gases.
Cronje
Frans J
FJ
Department of Medicine, and The Center for Hyperbaric Medicine and Environmental Physiology, Duke University Medical Center, Durham, NC 27710 USA.
Carraway
Martha S
MS
Freiberger
John J
JJ
Suliman
Hagir B
HB
Piantadosi
Claude A
CA
D000818:Animals; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002248:Carbon Monoxide / Q000032:analysis / Q000378:metabolism*; D006418:Heme / Q000032:analysis / Q000378:metabolism*; D006419:Heme Oxygenase (Decyclizing) / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism; D051547:Heme Oxygenase-1; D008665:Metalloporphyrins / Q000494:pharmacology; D018482:Muscle, Skeletal / Q000737:chemistry / Q000378:metabolism; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism*; D011524:Protoporphyrins / Q000494:pharmacology; D051381:Rats
D008665:Metalloporphyrins; D011524:Protoporphyrins; D006418:Heme; D002248:Carbon Monoxide; C032628:tin protoporphyrin IX; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; D010100:Oxygen